Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M305220200 on June 17, 2003

J. Biol. Chem., Vol. 278, Issue 36, 33887-33895, September 5, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/36/33887    most recent
M305220200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez-Hernandez, C. J.
Right arrow Articles by Murguía, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez-Hernandez, C. J.
Right arrow Articles by Murguía, J. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Immunosuppressant FK506 Uncovers a Positive Regulatory Cross-talk between the Hog1p and Gcn2p Pathways*

Carlos J. Rodriguez-Hernandez {ddagger} § ¶, Isabel Sanchez-Perez § || **, Rosario Gil-Mascarell {ddagger}, Abigail Rodríguez-Afonso {ddagger}, Armando Torres {ddagger}, Rosario Perona || and José R. Murguía {ddagger} {ddagger}{ddagger}

From the {ddagger}Research Unit, Hospital Universitario de Canarias, Ofra s/n-La Cuesta, 38320-La Laguna and the ||Instituto de Investigaciones Biomédicas (CSIC), C/Arturo Duperier 4, 28029-Madrid, Spain

The immunosuppressant Tacrolimus (FK506) has increased the survival rates of organ transplantation. FK506 exerts its immunosuppressive effect by inhibition of the protein phosphatase calcineurin in activated T-cells. Unfortunately, FK506 therapy is associated with undesired non-therapeutic effects involving targets other than calcineurin. To identify these targets we have addressed FK506 cellular toxicity in budding yeast. We show that FK506 increased cell sensitivity upon osmotic challenge independently of calcineurin and the FK506-binding proteins Fpr1p, -2p, -3p, and -4p. FK506 also induced strong amino acid starvation and activation of the general control (GCN) pathway. Tryptophan prototrophy or excess tryptophan overcame FK506 toxicity, showing that tryptophan deprivation mediated this effect. Mutation of the GCN3 and -4 genes partially alleviated FK506 toxicity, suggesting that activation of the GCN pathway by FK506 was also involved in osmotic tolerance. FK506 enhanced osmotic stress-dependent Hog1p kinase phosphorylation that was not accompanied by induction of a Hog1p-dependent reporter. Interestingly, deletion of the GCN2 gene suppressed FK506-dependent Hog1p hyperphosphorylation and restored Hog1p-dependent reporter activity. Conversely, deletion of the HOG1 gene impaired FK506-dependent activation of Gcn2p kinase and translation of a GCN4-LacZ reporter, highlighting functional cross-talk between the Gcn2p and Hog1p protein kinases. Taken together, these data demonstrate that both FK506-induced amino acid starvation and activation of the GCN pathway contribute to cell sensitivity to osmotic stress and reveal a positive regulatory loop between the Hog1p and Gcn2p pathways. Given the conserved nature of Gcn2p and Hog1p pathways, this mechanism of FK506 toxicity could be relevant to the non-therapeutic effects of FK506 therapy.


Received for publication, May 19, 2003 , and in revised form, June 13, 2003.

* This study was supported by Grants 00/0862, 01/1094, and 01/1626 from the Fondo de Investigaciones Sanitarias and by Grant 1FD87-1781 from FEDER. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Both authors contributed equally to this work.

Fellow of the Fondo de Investigaciones Sanitarias.

** Fellow of the Comunidad Autonoma de Madrid.

{ddagger}{ddagger} Currently sponsored as an investigator by the Fondo de Investigaciones Sanitarias. To whom correspondence should be addressed. Tel.: 34-922319338; Fax: 34-922319412; E-mail: jmurguia{at}hecit.es.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Thevissen, K. R. Ayscough, A. M. Aerts, W. Du, K. De Brucker, E. M. K. Meert, J. Ausma, M. Borgers, B. P. A. Cammue, and I. E. J. A. Francois
Miconazole Induces Changes in Actin Cytoskeleton prior to Reactive Oxygen Species Induction in Yeast
J. Biol. Chem., July 27, 2007; 282(30): 21592 - 21597.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
J. Delgado-Jarana, S. Sousa, F. Gonzalez, M. Rey, and A. Llobell
ThHog1 controls the hyperosmotic stress response in Trichoderma harzianum
Microbiology, June 1, 2006; 152(6): 1687 - 1700.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Narasimhan, K. A. Staschke, and R. C. Wek
Dimerization Is Required for Activation of eIF2 Kinase Gcn2 in Response to Diverse Environmental Stress Conditions
J. Biol. Chem., May 28, 2004; 279(22): 22820 - 22832.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement